Streetbeat News

Stock Prices

NXT

Nextracker Inc. (NASDAQ:NXT) reported Q3 earnings of 96 cents per share, surpassing estimates of 48 cents, and revenue of $710.43 million, beating estimates of $617.95 million. The company saw a 168% increase in adjusted EBITDA year-over-year and raised its FY 2024 revenue guidance to $2.425-$2.475 billion, with GAAP net income expected between $374-$429 million. Shares rose 18.20% to $53.51 in after-hours trading.

Portfolio Pulse from Ryan Gustafson

January 31, 2024 | 10:26 pm

OBT

Orange County Bancorp (NASDAQ:OBT) reported Q4 earnings of $1.44 per share, surpassing the $1.34 estimate, and sales of $25.89M, exceeding the $24.55M estimate. However, there was a 10.56% decrease in earnings and a slight 0.05% drop in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:26 pm

NEU

NewMarket Corporation reported a decrease in Q4 earnings per share from $9.26 to $8.38 and a 5.74% drop in sales to $643.35M compared to the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:24 pm

CLB

Core Laboratories (NYSE:CLB) reported Q4 adjusted EPS of $0.19, which was in line with analyst estimates, and sales of $128.21M, slightly beating the $127.77M estimate. However, this represents a 5% decrease in earnings per share compared to the same period last year, while sales saw a marginal 0.50% increase from the previous year.

Portfolio Pulse from bharat@benzinga.com

January 31, 2024 | 10:23 pm

TSLA

Elon Musk's tweet featuring a video of Tesla's humanoid robot, Optimus, caused a 25% surge in the price of the memecoin Optimus AI (OPTI). Blockchain entrepreneur Bruno Volcovinsky commented on the quick money-making opportunity this presents for investors. Crypto analyst Tiredwtf noted Musk's significant influence on crypto prices, referencing past surges in Dogecoin and other Elon-inspired coins. However, the price of OPTI has since corrected, falling back to around 20 cents.

Portfolio Pulse from Murtuza Merchant

January 31, 2024 | 10:22 pm

KPRX

Trading for KPRX has been halted at 5:10:00 p.m. ET due to pending news. The halt is in place to manage market orderliness and investor protection pending the release of material news.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:10 pm

NTLA

Intellia Therapeutics announced the publication of interim Phase 1 data for NTLA-2002 in the New England Journal of Medicine, showing its potential to eliminate angioedema attacks in patients with hereditary angioedema (HAE) after a single dose. The data also indicated that NTLA-2002 was well-tolerated across all dose levels.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:09 pm

CTVA

Corteva, an agriculture company, has provided its financial outlook for 2024, projecting net sales of $17.4 billion to $17.7 billion, which is in line with the estimated $17.608 billion. However, the company's adjusted earnings per share (EPS) forecast of $2.70 to $2.90 falls short of the estimated $3.01.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:07 pm

CTVA

Corteva, Inc. has announced its intention to repurchase approximately $1.0 billion of its shares in 2024. This buyback plan reflects the company's confidence in its financial strength and commitment to delivering value to its shareholders.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:04 pm

CTVA

Corteva (NYSE:CTVA) reported Q4 adjusted earnings per share (EPS) of $0.15, surpassing the analyst consensus estimate of $0.06 by 150%. However, this represents a 6.25% decrease from the $0.16 EPS reported in the same quarter last year. Sales reached $3.71 billion, exceeding the $3.62 billion estimate by 2.40%, but marking a 3.08% decline from the $3.83 billion in sales reported in the same period the previous year.

Portfolio Pulse from Benzinga Newsdesk

January 31, 2024 | 10:03 pm